0. Advocacy Graphic


  • April 19, 2019

    Arkansas and Kentucky Work Requirement Programs: Rulings Analysis

    An analysis of the impact of a federal judge's rulings striking down Medicaid work requirement programs in Kentucky and Arkansas.
  • April 11, 2019

    ASAM Adopts Public Policy Statement on the Ethical Use of Drug Testing in the Practice of Addiction Medicine

    On April 3, the Board of Directors of the American Society of Addiction Medicine (ASAM) approved a new policy statement: Public Policy Statement on the Ethical Use of Drug Testing in the Practice of Addiction Medicine. This Policy Statement includes recommendations on the clinical use of drug testing, appropriateness of presumptive testing, and the responsibilities of clinicians when testing for drugs.
  • April 4, 2019

    Part 2 Coalition Applauds Bipartisan Bills to Strengthen Addiction Treatment

    The Partnership to Amend 42 CFR Part 2 issued a statement in response to the introduction of identical bipartisan bills in both the House and Senate. The Overdose Prevention and Patient Safety Act, “OPPS Act”, was introduced by Congressmen Earl Blumenauer (D-OR) and Markwayne Mullin (R-OK) and the Protecting Jessica Grubb’s Legacy Act, “Legacy Act”, was introduced by Senators Shelley Moore Capito (R-WV) and Joe Manchin (D-WV).
  • April 2, 2019

    ASAM Signs Letter Calling for Funding to Grow the Addiction Medicine Workforce

    ASAM joined 18 other organizations in sending a letter urging the leadership of the House Appropriations Subcommittee on Labor, Health & Human Services, Education, and Related Agencies to fund programs in the Health Resources and Services Administration’s (HRSA) “Public Health and Preventive Medicine” line item in Fiscal Year 2020 (FY20) at the level of $24 million.
  • April 2, 2019

    ASAM Applauds Bipartisan Congressional Letters Urging Strategic Investments in the Addiction Treatment Workforce

    ASAM applauds a bipartisan group of lawmakers who sent letters this week urging their colleagues on the House Appropriations Committee to prioritize funding for two critical programs that would increase the ranks of qualified, well-trained addiction treatment professionals in high-need communities across the United States. Both programs were authorized in previous legislation and must now be funded.
  • March 14, 2019

    ASAM Writes to FDA Regarding Need for More Medication Treatment Options for Patients with SUD

    The dearth of FDA-approved pharmacotherapies for the treatment of substance use disorder (SUD) prompted ASAM to write to the Food and Drug Administration urging them to take into consideration the need for access to multiple treatment options for clinicians and their patients as they consider applications for new products to treat SUD.
  • February 25, 2019

    ASAM President Testifies Before Bipartisan Congressional Task Force on Opioid Overdose Epidemic

    Dr. Kelly J. Clark, president of ASAM, participated in a congressional roundtable sponsored by the House Bipartisan Heroin and Opioid Task Force. At the event, she urged lawmakers to make strategic investments in the substance use disorder (SUD) treatment workforce in order to close the addiction treatment gap and ensure the millions of Americans living with SUD are able to receive the care they need.
  • February 21, 2019

    ASAM Honors Recipients of 2019 Public Policy Award

    The American Society of Addiction Medicine (ASAM) is pleased to honor Representative Katherine Clark (D-MA-05) and Senator Rob Portman (R-OH) with the 2019 ASAM Public Policy Award.